ArticleBMC urology2025
Analysis of the efficacy of transurethral resection of prostate combined with transurethral incision of bladder neck when treating patients with small volume benign prostatic hyperplasia.
Article in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate the therapeutic effect of transurethral resection of the prostate (TURP) combined with transurethral incision of the bladder neck (TUIBN) compared to traditional TURP in treating benign prostatic hyperplasia (BPH), with a focus on minimizing bladder neck contracture.
methodsThis was a retrospective study analyzing data from 112 patients with small-volume BPH treated between December 2015 and May 2020, who were divided into a TURP group (control, N = 56) and a TURP + TUIBN group (observation, N = 56). The safety and effectiveness of the combined technique were assessed through perioperative complications, clinical symptoms (IPSS, QOL), urodynamics (Qmax, PVR, PV), and incidence of bladder neck contracture.
resultsNo significant difference was found in perioperative complications (P > 0.05). While IPSS and QOL scores were similar at 3 months (P > 0.05), the TURP + TUIBN group exhibited better urodynamic outcomes (Qmax, PVR; P < 0.05) and a significantly lower incidence of bladder neck contracture at 12 months (3.6% vs. 14.3%; P = 0.04). The observation group showed greater improvement in IPSS (from 22.1 ± 3.5 to 4.5 ± 0.5 vs. control: 22.3 ± 3.2 to 6.8 ± 1.2; P < 0.01) and Qmax (from 7.3 ± 2.1 to 19.6 ± 3.5 mL/s vs. control: 7.5 ± 1.9 to 17.8 ± 1.4 mL/s; P < 0.05). At 3-month follow-up, urodynamic improvements remained significant in the observation group (P < 0.05). Bladder neck contracture incidence was significantly lower in the observation group.
conclusionWithin the study's limits, TURP + TUIBN is a viable alternative to TURP alone for small-volume BPH, particularly effective in reducing bladder neck contracture, with additional improvements in functional outcomes. Further studies are warranted to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.